Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $4.95 in the prior trading day, Foghorn Therapeutics Inc (NASDAQ: FHTX) closed at $5.13, up 3.64%. In other words, the price has increased by $3.64 from its previous closing price. On the day, 80445.0 shares were traded. FHTX stock price reached its highest trading level at $5.17 during the session, while it also had its lowest trading level at $4.96.
Ratios:
Our goal is to gain a better understanding of FHTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.16 and its Current Ratio is at 3.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citizens JMP on April 23, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $9.
On January 30, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $10.
On September 03, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $18.Jefferies initiated its Buy rating on September 03, 2024, with a $18 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 20 ’24 when Costa Carlos sold 35,756 shares for $10.04 per share. The transaction valued at 358,990 led to the insider holds 0 shares of the business.
Costa Carlos sold 857 shares of FHTX for $8,716 on Sep 23 ’24. The Chief People Officer now owns 0 shares after completing the transaction at $10.17 per share. On Sep 18 ’24, another insider, Costa Carlos, who serves as the Chief People Officer of the company, sold 11,574 shares for $10.05 each. As a result, the insider received 116,319 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FHTX now has a Market Capitalization of 285953376 and an Enterprise Value of 76249456. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.17. Its current Enterprise Value per Revenue stands at 3.244 whereas that against EBITDA is -0.83.
Stock Price History:
The Beta on a monthly basis for FHTX is 3.05, which has changed by -0.032075465 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, FHTX has reached a high of $10.25, while it has fallen to a 52-week low of $2.94. The 50-Day Moving Average of the stock is 16.06%, while the 200-Day Moving Average is calculated to be -8.27%.
Shares Statistics:
The stock has traded on average 135.27K shares per day over the past 3-months and 184780 shares per day over the last 10 days, according to various share statistics. A total of 55.72M shares are outstanding, with a floating share count of 27.90M. Insiders hold about 49.95% of the company’s shares, while institutions hold 41.82% stake in the company. Shares short for FHTX as of 1749772800 were 1468613 with a Short Ratio of 10.86, compared to 1747267200 on 1068995. Therefore, it implies a Short% of Shares Outstanding of 1468613 and a Short% of Float of 4.01.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
